April 11, 2016April 11, 2016

Companies Announce They Will Jointly Develop Innovative Immuno-Oncology Gene Expression Assays

News

HalioDx SAS, an immuno-oncology diagnostics company, has entered an agreement with NanoString Technologies, a provider of products for translational research and molecular diagnostics, to jointly develop and commercialize advanced gene expression ... Read more

September 12, 2014September 12, 2014

NanoString Announces Novel Gene Expression Panel for Immuno-Oncology Research

News

NanoString Technologies, Inc., a company providing tools for translational research and molecular diagnostic products, has announced the introduction of a new highly multiplexed gene expression panel for the nCounter® Analysis System, ... Read more